Building a Better Stem Cell

In the future, stem cells created from our own skin cells will be used to renew damaged organs or grow new ones. We know this promise has often been made before, but the latest research in the lab of Dr. Jacob (Yaqub) Hanna is producing some solid findings that may make you believe in the possibility.

Just a little over a month ago, we reported that Hanna and his group had discovered a “brake” that keeps our cells from easily reverting to an embryonic-stem-cell-like state (induced pluripotent stem cells, or iPS cells). Removing that brake enabled them to ramp up the conversion process – in which inserting four genes into adult cells causes them to revert – from less than 1% efficiency to 100% efficiency.

Now they have refined the process further, producing iPS cells that are nearly identical to the earliest natural human embryonic stem cells. What is the difference between previous versions of iPS cells, which have been shown to differentiate into any number of different cell types, and the new ones?  It is the difference between cells that look a lot like embryonic stem cells, but still hold on to the ghosts of their previous forms (priming) and those that are naïve – that have no clue whatsoever as to what type of cell they “want to be when they grow up.” As an added bonus, the new cells can be kept for longer in their stem-like state, which should make them easier to use.

What Hanna and his group have done is to improve the recipe. The original four genes are still the basis of the reprogramming, but by adding another step or two, a carefully measured teaspoon of this and a pinch of that, they have taken things several steps closer to perfection.

Human naive iPS-derived cells (yellow/green) integrate into different tissues of developing host mouse embryo (red cells) Human naive iPS-derived cells (yellow/green) integrate into different tissues of developing host mouse embryo (red cells)

And the proof, as they say, is in the pudding. Or in this case, a “humanized” mouse embryo grown in the lab. Inserting the new iPS cells into a mouse blastocyst – a tiny ball of naïve embryonic stem cells – produced an embryo containing identifiable human tissue alongside the mouse tissue.

The next step, of course, is directing the differentiation of the embryonic tissue to produce specific human tissues and organs. Hanna and his group are already on it.

 

 

More like this

Getting cells to revert to a stem-like state – creating so-called induced pluripotent stem (iPS) cells – was a true revolution, but the technique invented in 2006 is only half the game. The first challenges include getting enough adult cells to undergo the “reprogramming” in culture to be of use…
First, there was the great hope of induced pluripotent stem cells (iPSCs), and then there was the inevitable letdown. When the announcement came, in 2006, that simple adult skin cells could be reprogrammed – reverted back to an embryonic stem cell state by the addition of just four genes – it…
News today has spread about new stem cell research out of China. Two teams used mouse fibroblasts, a kind of cell found in skin connective tissues, to create induced pluripotent skin cells (iPS), which were then used to create living mice. Their breakthrough research suggests that both cloning full…
Today three papers came out, two in Nature, and one in the inaugural edition of Cell Stem Cell, that basically confirm the results from last year's landmark manuscript by Kazutoshi Takahashi and Shinya Yamanaka (for details on this paper, see this post). Just to remind you, in that original…